Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Instructions to Expand Your Smash 1500's Presentation: Tips and Deceives - 2Satellites capture aftermath of Ethiopian volcano's 1st eruption in recorded history (images)
- 3Nearly 16,000 New York City nurses prepare to strike as contract talks stall
- 4Grasping the Qualifications Among Separation and Dissolution
- 56 Famous kind of practice on the planet
- Can a mammogram help identify heart disease?
- Former school bus aide pleads guilty to assaulting 3 autistic students in Colorado
- Tens of thousands protest as far-right AfD forms new youth group
- Rescuers give up hope for the humpback whale stranded in the Baltic Sea
- Viable Monetary Tips to Advance Your Monetary Circumstance
- The Iconic, Instantly Recognizable Plastic Chair That's Known All Around The World
- Lahav 433 head Asst.-Ch. Meni Benjamin named as police officer investigated for breach of trust
- Mossad unveils network of Hamas terror infrastructure across Europe
- Recalled "super greens" supplement linked to dozens of salmonella cases, CDC says
